TY - JOUR AU - Romero, P. AU - Cerottini, J. C. AU - Speiser, D. E. PY - 2006 DA - 2006// TI - The human T cell response to melanoma antigens JO - Adv Immunol VL - 92 UR - https://doi.org/10.1016/S0065-2776(06)92005-7 DO - 10.1016/S0065-2776(06)92005-7 ID - Romero2006 ER - TY - JOUR AU - Dunn, G. P. AU - Koebel, C. M. AU - Schreiber, R. D. PY - 2006 DA - 2006// TI - Interferons, immunity and cancer immunoediting JO - Nat Rev Immunol VL - 6 UR - https://doi.org/10.1038/nri1961 DO - 10.1038/nri1961 ID - Dunn2006 ER - TY - JOUR AU - Zhang, L. AU - Zhou, W. AU - Velculescu, V. E. AU - Kern, S. E. AU - Hruban, R. H. AU - Hamilton, S. R. AU - Vogelstein, B. AU - Kinzler, K. W. PY - 1997 DA - 1997// TI - Gene expression profiles in normal and cancer cells JO - Science VL - 276 UR - https://doi.org/10.1126/science.276.5316.1268 DO - 10.1126/science.276.5316.1268 ID - Zhang1997 ER - TY - JOUR AU - Dunn, G. P. AU - Bruce, A. T. AU - Ikeda, H. AU - Old, L. J. AU - Schreiber, R. D. PY - 2002 DA - 2002// TI - Cancer immunoediting: from immunosurveillance to tumor escape JO - Nat Immunol VL - 3 UR - https://doi.org/10.1038/ni1102-991 DO - 10.1038/ni1102-991 ID - Dunn2002 ER - TY - JOUR AU - Whiteside, T. L. PY - 2010 DA - 2010// TI - Immune responses to malignancies JO - J Allergy Clin Immunol VL - 125 UR - https://doi.org/10.1016/j.jaci.2009.09.045 DO - 10.1016/j.jaci.2009.09.045 ID - Whiteside2010 ER - TY - JOUR AU - Galluzzi, L. AU - Maiuri, M. C. AU - Vitale, I. AU - Zischka, H. AU - Castedo, M. AU - Zitvogel, L. AU - Kroemer, G. PY - 2007 DA - 2007// TI - Cell death modalities: classification and pathophysiological implications JO - Cell Death Differ VL - 14 UR - https://doi.org/10.1038/sj.cdd.4402148 DO - 10.1038/sj.cdd.4402148 ID - Galluzzi2007 ER - TY - JOUR AU - Ma, Y. AU - Kepp, O. AU - Ghiringhelli, F. AU - Apetoh, L. AU - Aymeric, L. AU - Locher, C. AU - Tesniere, A. AU - Martins, I. AU - Ly, A. AU - Haynes, N. M. AU - Smyth, M. J. AU - Kroemer, G. AU - Zitvogel, L. PY - 2010 DA - 2010// TI - Chemotherapy and radiotherapy: cryptic anticancer vaccines JO - Semin Immunol VL - 22 UR - https://doi.org/10.1016/j.smim.2010.03.001 DO - 10.1016/j.smim.2010.03.001 ID - Ma2010 ER - TY - JOUR AU - Formenti, S. C. AU - Demaria, S. PY - 2013 DA - 2013// TI - Combining radiotherapy and cancer immunotherapy: a paradigm shift JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djs629 DO - 10.1093/jnci/djs629 ID - Formenti2013 ER - TY - JOUR AU - Watters, D. PY - 1999 DA - 1999// TI - Molecular mechanisms of ionizing radiation-induced apoptosis JO - Immunol Cell Biol VL - 77 UR - https://doi.org/10.1046/j.1440-1711.1999.00824.x DO - 10.1046/j.1440-1711.1999.00824.x ID - Watters1999 ER - TY - JOUR AU - Larsson, M. AU - Fonteneau, J. F. AU - Bhardwaj, N. PY - 2001 DA - 2001// TI - Dendritic cells resurrect antigens from dead cells JO - Trends Immunol VL - 22 UR - https://doi.org/10.1016/S1471-4906(01)01860-9 DO - 10.1016/S1471-4906(01)01860-9 ID - Larsson2001 ER - TY - JOUR AU - McBride, W. H. AU - Chiang, C. S. AU - Olson, J. L. AU - Wang, C. C. AU - Hong, J. H. AU - Pajonk, F. AU - Dougherty, G. J. AU - Iwamoto, K. S. AU - Pervan, M. AU - Liao, Y. P. PY - 2004 DA - 2004// TI - A sense of danger from radiation JO - Radiat Res VL - 162 UR - https://doi.org/10.1667/RR3196 DO - 10.1667/RR3196 ID - McBride2004 ER - TY - JOUR AU - Ishihara, H. AU - Tsuneoka, K. AU - Dimchev, A. B. AU - Shikita, M. PY - 1993 DA - 1993// TI - Induction of the expression of the interleukin-1 beta gene in mouse spleen by ionizing radiation JO - Radiat Res VL - 133 UR - https://doi.org/10.2307/3578216 DO - 10.2307/3578216 ID - Ishihara1993 ER - TY - JOUR AU - Hallahan, D. E. AU - Spriggs, D. R. AU - Beckett, M. A. AU - Kufe, D. W. AU - Weichselbaum, R. R. PY - 1989 DA - 1989// TI - Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation JO - Proc Natl Acad Sci U S A VL - 86 UR - https://doi.org/10.1073/pnas.86.24.10104 DO - 10.1073/pnas.86.24.10104 ID - Hallahan1989 ER - TY - JOUR AU - Friedman, E. J. PY - 2002 DA - 2002// TI - Immune modulation by ionizing radiation and its implications for cancer immunotherapy JO - Curr Pharm Des VL - 8 UR - https://doi.org/10.2174/1381612023394089 DO - 10.2174/1381612023394089 ID - Friedman2002 ER - TY - JOUR AU - Garnett, C. T. AU - Palena, C. AU - Chakraborty, M. AU - Tsang, K. Y. AU - Schlom, J. AU - Hodge, J. W. PY - 2004 DA - 2004// TI - Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-1525 DO - 10.1158/0008-5472.CAN-04-1525 ID - Garnett2004 ER - TY - JOUR AU - Ganss, R. AU - Ryschich, E. AU - Klar, E. AU - Arnold, B. AU - Hammerling, G. J. PY - 2002 DA - 2002// TI - Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication JO - Cancer Res VL - 62 ID - Ganss2002 ER - TY - JOUR AU - Brooks, P. C. AU - Roth, J. M. AU - Lymberis, S. C. AU - DeWyngaert, K. AU - Broek, D. AU - Formenti, S. C. PY - 2002 DA - 2002// TI - Ionizing radiation modulates the exposure of the HUIV26 cryptic epitope within collagen type IV during angiogenesis JO - Int J Radiat Oncol Biol Phys VL - 54 UR - https://doi.org/10.1016/S0360-3016(02)03748-3 DO - 10.1016/S0360-3016(02)03748-3 ID - Brooks2002 ER - TY - JOUR AU - Hallahan, D. AU - Kuchibhotla, J. AU - Wyble, C. PY - 1996 DA - 1996// TI - Cell adhesion molecules mediate radiationinduced leukocyte adhesion to the vascular endothelium JO - Cancer Res VL - 56 ID - Hallahan1996 ER - TY - JOUR AU - Demaria, S. AU - Ng, B. AU - Devitt, M. L. AU - Babb, J. S. AU - Kawashima, N. AU - Liebes, L. AU - Formenti, S. C. PY - 2004 DA - 2004// TI - Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated JO - Int J Radiat Oncol Biol Phys VL - 58 UR - https://doi.org/10.1016/j.ijrobp.2003.09.012 DO - 10.1016/j.ijrobp.2003.09.012 ID - Demaria2004 ER - TY - JOUR AU - Demaria, S. AU - Bhardwaj, N. AU - McBride, W. H. AU - Formenti, S. C. PY - 2005 DA - 2005// TI - Combining radiotherapy and immunotherapy: a revived partnership JO - Int J Radiat Oncol Biol Phys VL - 63 UR - https://doi.org/10.1016/j.ijrobp.2005.06.032 DO - 10.1016/j.ijrobp.2005.06.032 ID - Demaria2005 ER - TY - JOUR AU - Demaria, S. AU - Formenti, S. C. PY - 2007 DA - 2007// TI - Sensors of ionizing radiation effects on the immunological microenvironment of cancer JO - Int J Radiat Biol VL - 83 UR - https://doi.org/10.1080/09553000701481816 DO - 10.1080/09553000701481816 ID - Demaria2007 ER - TY - JOUR AU - Rosenberg, S. A. AU - Yang, J. C. AU - White, D. E. AU - Steinberg, S. M. PY - 1998 DA - 1998// TI - Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response JO - Ann Surg VL - 228 UR - https://doi.org/10.1097/00000658-199809000-00004 DO - 10.1097/00000658-199809000-00004 ID - Rosenberg1998 ER - TY - JOUR AU - Fisher, R. I. AU - Rosenberg, S. A. AU - Fyfe, G. PY - 2000 DA - 2000// TI - Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma JO - Cancer J Sci Am VL - 6 ID - Fisher2000 ER - TY - JOUR AU - Atkins, M. B. AU - Kunkel, L. AU - Sznol, M. AU - Rosenberg, S. A. PY - 2000 DA - 2000// TI - High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update JO - Cancer J Sci Am VL - 6 ID - Atkins2000 ER - TY - JOUR AU - Bachmann, M. F. AU - Oxenius, A. PY - 2007 DA - 2007// TI - Interleukin 2: from immunostimulation to immunoregulation and back again JO - EMBO Rep VL - 8 UR - https://doi.org/10.1038/sj.embor.7401099 DO - 10.1038/sj.embor.7401099 ID - Bachmann2007 ER - TY - JOUR AU - Laurence, A. AU - Tato, C. M. AU - Davidson, T. S. AU - Kanno, Y. AU - Chen, Z. AU - Yao, Z. AU - Blank, R. B. AU - Meylan, F. AU - Siegel, R. AU - Hennighausen, L. AU - Shevach, E. M. AU - O’shea, J. J. PY - 2007 DA - 2007// TI - Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation JO - Immunity VL - 26 UR - https://doi.org/10.1016/j.immuni.2007.02.009 DO - 10.1016/j.immuni.2007.02.009 ID - Laurence2007 ER - TY - JOUR AU - Cesana, G. C. AU - DeRaffele, G. AU - Cohen, S. AU - Moroziewicz, D. AU - Mitcham, J. AU - Stoutenburg, J. AU - Cheung, K. AU - Hesdorffer, C. AU - Kim-Schulze, S. AU - Kaufman, H. L. PY - 2006 DA - 2006// TI - Characterization of CD4 + CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.6830 DO - 10.1200/JCO.2005.03.6830 ID - Cesana2006 ER - TY - JOUR AU - Malek, T. R. PY - 2008 DA - 2008// TI - The biology of interleukin-2 JO - Annu Rev Immunol VL - 26 UR - https://doi.org/10.1146/annurev.immunol.26.021607.090357 DO - 10.1146/annurev.immunol.26.021607.090357 ID - Malek2008 ER - TY - JOUR AU - Atkins, M. B. AU - Lotze, M. T. AU - Dutcher, J. P. AU - Fisher, R. I. AU - Weiss, G. AU - Margolin, K. AU - Abrams, J. AU - Sznol, M. AU - Parkinson, D. AU - Hawkins, M. AU - Paradise, C. AU - Kunkel, L. AU - Rosenberg, S. A. PY - 1999 DA - 1999// TI - High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 JO - J Clin Oncol VL - 17 ID - Atkins1999 ER - TY - JOUR AU - Legha, S. S. AU - Gianan, M. A. AU - Plager, C. AU - Eton, O. E. AU - Papadopoulous, N. E. PY - 1996 DA - 1996// TI - Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma JO - Cancer VL - 77 UR - https://doi.org/3.0.CO;2-4 DO - 3.0.CO;2-4 ID - Legha1996 ER - TY - JOUR AU - Fyfe, G. AU - Fisher, R. I. AU - Rosenberg, S. A. AU - Sznol, M. AU - Parkinson, D. R. AU - Louie, A. C. PY - 1995 DA - 1995// TI - Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy JO - J Clin Oncol VL - 13 ID - Fyfe1995 ER - TY - JOUR AU - Kammula, U. S. AU - White, D. E. AU - Rosenberg, S. A. PY - 1998 DA - 1998// TI - Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer JO - Cancer VL - 83 UR - https://doi.org/3.0.CO;2-M DO - 3.0.CO;2-M ID - Kammula1998 ER - TY - JOUR AU - Schwartzentruber, D. J. PY - 2001 DA - 2001// TI - Guidelines for the safe administration of high-dose interleukin-2 JO - J Immunother VL - 24 UR - https://doi.org/10.1097/00002371-200107000-00004 DO - 10.1097/00002371-200107000-00004 ID - Schwartzentruber2001 ER - TY - JOUR AU - Sondel, P. M. AU - Kohler, P. C. AU - Hank, J. A. AU - Moore, K. H. AU - Rosenthal, N. S. AU - Sosman, J. A. AU - Bechhofer, R. AU - Storer, B. PY - 1988 DA - 1988// TI - Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer JO - Cancer Res VL - 48 ID - Sondel1988 ER - TY - JOUR AU - Dillman, R. O. AU - Oldham, R. K. AU - Tauer, K. W. AU - Orr, D. W. AU - Barth, N. M. AU - Blumenschein, G. AU - Arnold, J. AU - Birch, R. AU - West, W. H. PY - 1991 DA - 1991// TI - Continuous interleukin-2 and lymphokineactivated killer cells for advanced cancer: a National Biotherapy Study Group trial JO - J Clin Oncol VL - 9 ID - Dillman1991 ER - TY - JOUR AU - Dillman, R. O. AU - Oldham, R. K. AU - Barth, N. M. AU - Cohen, R. J. AU - Minor, D. R. AU - Birch, R. AU - Yannelli, J. R. AU - Maleckar, J. R. AU - Sferruzza, A. AU - Arnold, J. PY - 1991 DA - 1991// TI - Continuous interleukin-2 and tumorinfiltrating lymphocytes as treatment of advanced melanoma. a national biotherapy study group trial JO - Cancer VL - 68 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Dillman1991 ER - TY - JOUR AU - Quan, W. AU - Brick, W. AU - Vinogradov, M. AU - Taylor, W. C. AU - Khan, N. AU - Burgess, R. PY - 2004 DA - 2004// TI - Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanoma JO - Cancer Biother Radiopharm VL - 19 UR - https://doi.org/10.1089/1084978041424972 DO - 10.1089/1084978041424972 ID - Quan2004 ER - TY - JOUR AU - Hinrichs, C. S. AU - Palmer, D. C. AU - Rosenberg, S. A. AU - Restifo, N. P. PY - 2005 DA - 2005// TI - Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells JO - J Immunother VL - 28 UR - https://doi.org/10.1097/01.cji.0000177999.95831.7b DO - 10.1097/01.cji.0000177999.95831.7b ID - Hinrichs2005 ER - TY - JOUR AU - Hutson, T. E. AU - Quinn, D. I. PY - 2005 DA - 2005// TI - Cytokine therapy: a standard of care for metastatic renal cell carcinoma? JO - Clin Genitourin Cancer VL - 4 UR - https://doi.org/10.3816/CGC.2005.n.030 DO - 10.3816/CGC.2005.n.030 ID - Hutson2005 ER - TY - JOUR AU - Gore, M. E. AU - De Mulder, P. PY - 2008 DA - 2008// TI - Establishing the role of cytokine therapy in advanced renal cell carcinoma JO - BJU Int VL - 101 UR - https://doi.org/10.1111/j.1464-410X.2008.07435.x DO - 10.1111/j.1464-410X.2008.07435.x ID - Gore2008 ER - TY - JOUR AU - McDermott, D. F. AU - Atkins, M. B. PY - 2006 DA - 2006// TI - Interleukin-2 therapy of metastatic renal cell carcinoma–predictors of response JO - Semin Oncol VL - 33 UR - https://doi.org/10.1053/j.seminoncol.2006.06.004 DO - 10.1053/j.seminoncol.2006.06.004 ID - McDermott2006 ER - TY - JOUR AU - McDermott, D. F. PY - 2007 DA - 2007// TI - Update on the application of interleukin-2 in the treatment of renal cell carcinoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1872 DO - 10.1158/1078-0432.CCR-06-1872 ID - McDermott2007 ER - TY - JOUR AU - Kirkwood, J. M. AU - Tarhini, A. A. PY - 2009 DA - 2009// TI - Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.1540 DO - 10.1200/JCO.2008.21.1540 ID - Kirkwood2009 ER - TY - JOUR AU - Sabatino, M. AU - Kim-Schulze, S. AU - Panelli, M. C. AU - Stroncek, D. AU - Wang, E. AU - Taback, B. AU - Kim, D. W. AU - Deraffele, G. AU - Pos, Z. AU - Marincola, F. M. AU - Kaufman, H. L. PY - 2009 DA - 2009// TI - Serum vascularendothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.1106 DO - 10.1200/JCO.2008.19.1106 ID - Sabatino2009 ER - TY - JOUR AU - Wolchok, J. D. AU - Hoos, A. AU - O’Day, S. AU - Weber, J. S. AU - Hamid, O. AU - Lebbe, C. AU - Maio, M. AU - Binder, M. AU - Bohnsack, O. AU - Nichol, G. AU - Humphrey, R. AU - Hodi, F. S. PY - 2009 DA - 2009// TI - Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1624 DO - 10.1158/1078-0432.CCR-09-1624 ID - Wolchok2009 ER - TY - JOUR AU - Najjar, Y. G. AU - Rini, B. I. PY - 2012 DA - 2012// TI - Novel agents in renal carcinoma: a reality check JO - Ther Adv Med Oncol VL - 4 UR - https://doi.org/10.1177/1758834012443725 DO - 10.1177/1758834012443725 ID - Najjar2012 ER - TY - JOUR AU - Chapman, P. B. AU - Hauschild, A. AU - Robert, C. AU - Haanen, J. B. AU - Ascierto, P. AU - Larkin, J. AU - Dummer, R. AU - Garbe, C. AU - Testori, A. AU - Maio, M. AU - Hogg, D. AU - Lorigan, P. AU - Lebbe, C. AU - Jouary, T. AU - Schadendorf, D. AU - Ribas, A. AU - O’Day, S. J. AU - Sosman, J. A. AU - Kirkwood, J. M. AU - Eggermont, A. M. AU - Dreno, B. AU - Nolop, K. AU - Li, J. AU - Nelson, B. AU - Hou, J. AU - Lee, R. J. AU - Flaherty, K. T. AU - McArthur, G. A. PY - 2011 DA - 2011// TI - Improved survival with vemurafenib in melanoma with BRAF V600E mutation JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1103782 DO - 10.1056/NEJMoa1103782 ID - Chapman2011 ER - TY - JOUR AU - Meric-Bernstam, F. AU - Gonzalez-Angulo, A. M. PY - 2009 DA - 2009// TI - Targeting the mTOR signalling network for cancer therapy JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.0766 DO - 10.1200/JCO.2008.20.0766 ID - Meric-Bernstam2009 ER - TY - JOUR AU - Flaherty, K. T. AU - Puzanov, I. AU - Kim, K. B. AU - Ribas, A. AU - McArthur, G. A. AU - Sosman, J. A. AU - O’Dwyer, P. J. AU - Lee, R. J. AU - Grippo, J. F. AU - Nolop, K. AU - Chapman, P. B. PY - 2010 DA - 2010// TI - Inhibition of mutated, activated BRAF in metastatic melanoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1002011 DO - 10.1056/NEJMoa1002011 ID - Flaherty2010 ER - TY - JOUR AU - Robert, C. AU - Schadendorf, D. AU - Messina, M. AU - Hodi, F. S. AU - O’Day, S. PY - 2013 DA - 2013// TI - Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3080 DO - 10.1158/1078-0432.CCR-12-3080 ID - Robert2013 ER - TY - JOUR AU - Amin, A. AU - White, R. L. PY - 2013 DA - 2013// TI - High-dose interleukin-2: is it still indicated for melanoma and RCC in an era of targeted therapies? JO - Oncology (Williston Park) VL - 27 ID - Amin2013 ER - TY - JOUR AU - Hamid, O. AU - Schmidt, H. AU - Nissan, A. AU - Ridolfi, L. AU - Aamdal, S. AU - Hansson, J. AU - Guida, M. AU - Hyams, D. M. AU - Gomez, H. AU - Bastholt, L. AU - Chasalow, S. D. AU - Berman, D. PY - 2011 DA - 2011// TI - A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma JO - J Transl Med VL - 9 UR - https://doi.org/10.1186/1479-5876-9-204 DO - 10.1186/1479-5876-9-204 ID - Hamid2011 ER - TY - JOUR AU - Ascierto, P. A. AU - Capone, M. AU - Urba, W. J. AU - Bifulco, C. B. AU - Botti, G. AU - Lugli, A. AU - Marincola, F. M. AU - Ciliberto, G. AU - Galon, J. AU - Fox, B. A. PY - 2013 DA - 2013// TI - The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment JO - J Transl Med VL - 11 UR - https://doi.org/10.1186/1479-5876-11-54 DO - 10.1186/1479-5876-11-54 ID - Ascierto2013 ER -